SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021895
Filing Date
2022-11-03
Accepted
2022-11-03 16:18:50
Documents
79
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q grts-20220930.htm   iXBRL 10-Q 3663733
2 EX-10.1 grts-ex10_1.htm EX-10.1 1179363
3 EX-31.1 grts-ex31_1.htm EX-31.1 25825
4 EX-31.2 grts-ex31_2.htm EX-31.2 25859
5 EX-32.1 grts-ex32_1.htm EX-32.1 24270
  Complete submission text file 0000950170-22-021895.txt   15613509

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grts-20220930_pre.xml EX-101.PRE 485029
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grts-20220930_cal.xml EX-101.CAL 59211
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grts-20220930_lab.xml EX-101.LAB 635759
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grts-20220930_def.xml EX-101.DEF 308222
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grts-20220930.xsd EX-101.SCH 87570
73 EXTRACTED XBRL INSTANCE DOCUMENT grts-20220930_htm.xml XML 3207284
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 221358310
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences